Skip to main content
Top
Published in: Clinical Rheumatology 2/2008

01-02-2008 | Review Article

The interrelation of glutathione reductase, catalase, glutathione peroxidase, superoxide dismutase, and glucose-6-phosphate in the pathogenesis of rheumatoid arthritis

Authors: Banu Kalpakcioglu, Kazim Şenel

Published in: Clinical Rheumatology | Issue 2/2008

Login to get access

Abstract

Rheumatoid arthritis (RA) is the most common form of inflammatory arthritis, a systemic autoimmune disease characterized by chronic inflammation of the synovial joints, ultimately leading to joint destruction and permanent disability, affecting 1% of the world population. Oxidative stress in rheumatoid inflammation, due to the fact that antioxidant systems are impaired in RA and caused by fee radicals, might have an essential role in etiology of RA. This review includes the interrelation of antioxidants against free radicals in RA patients. There is much evidence that antioxidant team that covers glutathione reductase, catalase, glutathione peroxidase, superoxide dismutase, and glucose-6-phopshate destroy reactive oxygen species and other free radicals through enzymatic as well as nonenzymatic means. The change in relative levels of antioxidants vis-à-vis free radical formation and level could be used as indicators for effective and earlier diagnosis of RA.
Literature
1.
go back to reference Glossop JR, Dawes PT, Mattey DL (2006) Association between cigarette smoking and release of tumour necrosis factor and its soluble receptors by peripheral blood mononuclear cells in patients with rheumatoid arthritis. Rheumatology 45:1223–1229PubMedCrossRef Glossop JR, Dawes PT, Mattey DL (2006) Association between cigarette smoking and release of tumour necrosis factor and its soluble receptors by peripheral blood mononuclear cells in patients with rheumatoid arthritis. Rheumatology 45:1223–1229PubMedCrossRef
2.
go back to reference Martinez A, Valdivia A, Pascual-Salcedo D et al (2005) PADI4 polymorphisms are not associated with rheumatoid arthritis in the Spanish population. Rheumatology 44:1263–1266PubMedCrossRef Martinez A, Valdivia A, Pascual-Salcedo D et al (2005) PADI4 polymorphisms are not associated with rheumatoid arthritis in the Spanish population. Rheumatology 44:1263–1266PubMedCrossRef
3.
go back to reference American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines (2002) Guidelines for the management of rheumatoid arthritis. Arthritis Rheuma 46:328–346CrossRef American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines (2002) Guidelines for the management of rheumatoid arthritis. Arthritis Rheuma 46:328–346CrossRef
4.
go back to reference Evans P, Halliwell B (1999) Free radicals and hearing: cause, consequence, and criterie. Ann NY Acad Sci 884:19–40PubMedCrossRef Evans P, Halliwell B (1999) Free radicals and hearing: cause, consequence, and criterie. Ann NY Acad Sci 884:19–40PubMedCrossRef
5.
go back to reference Freeman BA, Crapo JD (1982) Free radicals and tissue injury. Lab Invest 47:412–426PubMed Freeman BA, Crapo JD (1982) Free radicals and tissue injury. Lab Invest 47:412–426PubMed
6.
go back to reference Lunec J, Blake D (1990) Oxygen free radicals: their relevance to disease processes. In: Cohen D, Lewis B, Albert KGMM (eds) The metabolic and moleculer basis of acquired disease. Balliere Tindall, London, pp 189–212 Lunec J, Blake D (1990) Oxygen free radicals: their relevance to disease processes. In: Cohen D, Lewis B, Albert KGMM (eds) The metabolic and moleculer basis of acquired disease. Balliere Tindall, London, pp 189–212
7.
go back to reference Barbor DA, Harris SR (1994) Oxygen free radicals and antioxidants: a review. Am Pharm 34:26–35 Barbor DA, Harris SR (1994) Oxygen free radicals and antioxidants: a review. Am Pharm 34:26–35
8.
go back to reference Greenwald RA (1991) Oxygen radicals, inflammation, and arthritis: pathophysiological considerations and implications for treatment. Semin Arthritis Rheum 20:219–240PubMedCrossRef Greenwald RA (1991) Oxygen radicals, inflammation, and arthritis: pathophysiological considerations and implications for treatment. Semin Arthritis Rheum 20:219–240PubMedCrossRef
9.
go back to reference Jasin HE (1997) Mechanism of tissue damage in rheumatoid arthritis. In: Koopman WJ (ed) Arthritis and allied conditions: textbook of rheumatology. Williams Wilkies, Baltimore, pp 1017–1036 Jasin HE (1997) Mechanism of tissue damage in rheumatoid arthritis. In: Koopman WJ (ed) Arthritis and allied conditions: textbook of rheumatology. Williams Wilkies, Baltimore, pp 1017–1036
10.
go back to reference Imadaya A, Terasawa K, Tosa H (1988) Erythrocyte antioxydant enzymes are reduced in patients with rheumatoid arthritis. J Rheumatol 15:1628–1631PubMed Imadaya A, Terasawa K, Tosa H (1988) Erythrocyte antioxydant enzymes are reduced in patients with rheumatoid arthritis. J Rheumatol 15:1628–1631PubMed
11.
go back to reference Semble LE (1995) Rheumatoid arthritis. New approaches for its evaluation and management. Arch Phys Med Rehabil 76:190–200PubMedCrossRef Semble LE (1995) Rheumatoid arthritis. New approaches for its evaluation and management. Arch Phys Med Rehabil 76:190–200PubMedCrossRef
12.
go back to reference Harris ED (1993) Etiology and pathogenesis of rheumatoid arthritis. In: Kelley WN, Harris ED, Ruddy S, Sledge CB (eds) Textbook of rheumatology. WB Saunders, Philadelphia, pp 833–873 Harris ED (1993) Etiology and pathogenesis of rheumatoid arthritis. In: Kelley WN, Harris ED, Ruddy S, Sledge CB (eds) Textbook of rheumatology. WB Saunders, Philadelphia, pp 833–873
13.
go back to reference Heliövaara M, Knekt P, Aho K et al (1994) Serum antioxidant and risk of rheumatoid arthritis. Ann Rheum Dis 53:51–53PubMed Heliövaara M, Knekt P, Aho K et al (1994) Serum antioxidant and risk of rheumatoid arthritis. Ann Rheum Dis 53:51–53PubMed
14.
go back to reference Blake DR, Hall ND, Treby DA et al (1981) Protection against superoxide and hydrogen peroxide in synovial fluid from rheumatoid patients. Clin Sci 61:483–486PubMed Blake DR, Hall ND, Treby DA et al (1981) Protection against superoxide and hydrogen peroxide in synovial fluid from rheumatoid patients. Clin Sci 61:483–486PubMed
15.
go back to reference Mazetti I, Grigolo B, Borzi RM et al (1996) Serum copper/zinc superoxide dismutase levels in patients with rheumatoid arthritis. Int J Clin Lab Res 26:245–249CrossRef Mazetti I, Grigolo B, Borzi RM et al (1996) Serum copper/zinc superoxide dismutase levels in patients with rheumatoid arthritis. Int J Clin Lab Res 26:245–249CrossRef
16.
go back to reference Shah ZA, Vohora SB (2002) Antioxidant/restorative effects of calcined gold preparations used in indian systems of medicine against global and focal models of ischaemia. Pharm & Toxicol 90:254–259CrossRef Shah ZA, Vohora SB (2002) Antioxidant/restorative effects of calcined gold preparations used in indian systems of medicine against global and focal models of ischaemia. Pharm & Toxicol 90:254–259CrossRef
17.
go back to reference Rowley D, Gutteridge MC, Blake D et al (1984) Lipid peroxidation in rheumatoid arthritis: thiobarbituric acid-reactive material and catalytic iron salts in synovial fluid from rheumatoid patients. Clin Sci 66:691–695PubMed Rowley D, Gutteridge MC, Blake D et al (1984) Lipid peroxidation in rheumatoid arthritis: thiobarbituric acid-reactive material and catalytic iron salts in synovial fluid from rheumatoid patients. Clin Sci 66:691–695PubMed
18.
go back to reference Gambhir JK, Lali P, Jain AK (1997) Correlation between blood antioxidant levels and lipid peroxidation in rheumatoid arthritis. Clin Biochem 30:351–355PubMedCrossRef Gambhir JK, Lali P, Jain AK (1997) Correlation between blood antioxidant levels and lipid peroxidation in rheumatoid arthritis. Clin Biochem 30:351–355PubMedCrossRef
19.
go back to reference Miyata T, Ishiguro N, Yasuda Y et al (1998) Increased pentosidine, an advanced glycation end product, in plasma and synovial fluid from patients with rheumatoid arthritis and its relation with inflammatory markers. Biochem Biophys Res Commun 244:45–49PubMedCrossRef Miyata T, Ishiguro N, Yasuda Y et al (1998) Increased pentosidine, an advanced glycation end product, in plasma and synovial fluid from patients with rheumatoid arthritis and its relation with inflammatory markers. Biochem Biophys Res Commun 244:45–49PubMedCrossRef
20.
go back to reference Chapman AP, Antoniw P, Spitali M et al (1999) Therapeutic antibody fragments with prolonged in vivo half-lives. Nat Biotechnol 17:780–783PubMedCrossRef Chapman AP, Antoniw P, Spitali M et al (1999) Therapeutic antibody fragments with prolonged in vivo half-lives. Nat Biotechnol 17:780–783PubMedCrossRef
22.
go back to reference Karincaoglu Y, Batcioglu K, Erdem T et al (2005) The levels of plasma and salivary antioxidants in the patient with recurrent aphthous stomatitis. J Oral Pathol & Med 34:7–12CrossRef Karincaoglu Y, Batcioglu K, Erdem T et al (2005) The levels of plasma and salivary antioxidants in the patient with recurrent aphthous stomatitis. J Oral Pathol & Med 34:7–12CrossRef
23.
go back to reference Gul M, Kutay FZ, Temocin S et al (2000) Cellular and clinical implications of glutathione. Indian J Exp Biol 38:625–634PubMed Gul M, Kutay FZ, Temocin S et al (2000) Cellular and clinical implications of glutathione. Indian J Exp Biol 38:625–634PubMed
24.
go back to reference Taysi S, Polat F, Gul M et al (2002) Lipid peroxidation, some extracellular antioxidants, and antioxidant enzymes in serum of patients with rheumatoid arthritis. Rheumatol Int 21:200–204PubMedCrossRef Taysi S, Polat F, Gul M et al (2002) Lipid peroxidation, some extracellular antioxidants, and antioxidant enzymes in serum of patients with rheumatoid arthritis. Rheumatol Int 21:200–204PubMedCrossRef
25.
go back to reference Kalavacherla US, Ishaq M, Rao URK et al (1994) Malondialdehyde as a sensitive marker of inflammation in patients with rheumatoid arthritis. J Assoc Phys India 42:775–776 Kalavacherla US, Ishaq M, Rao URK et al (1994) Malondialdehyde as a sensitive marker of inflammation in patients with rheumatoid arthritis. J Assoc Phys India 42:775–776
26.
go back to reference Bae SC, Kim SJ, Sung MK (2003) Inadequate antioxidant nutrient intake and altered plasma antioxidant status of rheumatoid arthritis patients. J Am Coll Nutr 22:311–315PubMed Bae SC, Kim SJ, Sung MK (2003) Inadequate antioxidant nutrient intake and altered plasma antioxidant status of rheumatoid arthritis patients. J Am Coll Nutr 22:311–315PubMed
27.
go back to reference Olivieri O, Girelli D, Trevisan MT et al (1991) Red blood cell susceptibility to lipid peroxidation, membrane lipid composition and antioxidant enzymes in patient with rheumatoid arthritis. J Rheumatol 18:1263–1264PubMed Olivieri O, Girelli D, Trevisan MT et al (1991) Red blood cell susceptibility to lipid peroxidation, membrane lipid composition and antioxidant enzymes in patient with rheumatoid arthritis. J Rheumatol 18:1263–1264PubMed
28.
go back to reference Jira W, Spiteller G, Richter A (1997) Increased levels of lipid oxidation products in low density lipoproteins of patients suffering from rheumatoid arthritis. Chem Phys Lipids 87:81–89PubMedCrossRef Jira W, Spiteller G, Richter A (1997) Increased levels of lipid oxidation products in low density lipoproteins of patients suffering from rheumatoid arthritis. Chem Phys Lipids 87:81–89PubMedCrossRef
29.
go back to reference Pullar T, Zoma A, Capell HA et al (1987) Alteration of thiol and superoxide dismutase status in rheumatoid arthritis treated with sulphasalazine. Br J Rheumatol 26:202–206PubMedCrossRef Pullar T, Zoma A, Capell HA et al (1987) Alteration of thiol and superoxide dismutase status in rheumatoid arthritis treated with sulphasalazine. Br J Rheumatol 26:202–206PubMedCrossRef
30.
go back to reference Rae KJ, Mackay CN, McNeil CJ et al (1986) Early and late changes in sulphydryl group and copper protein concentrations and activities during drug treatment with aurothiomalate and auranofin. Ann Rheum Dis 45:839–846PubMedCrossRef Rae KJ, Mackay CN, McNeil CJ et al (1986) Early and late changes in sulphydryl group and copper protein concentrations and activities during drug treatment with aurothiomalate and auranofin. Ann Rheum Dis 45:839–846PubMedCrossRef
31.
go back to reference Nivsarkar M (2000) Improvement in circulating superoxide dismutase levels: role of nonsteroidal anti-inflammatory drugs in rheumatoid arthritis. Biochem Biophys Res Commun 270:714–716PubMedCrossRef Nivsarkar M (2000) Improvement in circulating superoxide dismutase levels: role of nonsteroidal anti-inflammatory drugs in rheumatoid arthritis. Biochem Biophys Res Commun 270:714–716PubMedCrossRef
32.
go back to reference Rister M, Bauermeister K (1982) Superoxid-Dismutase und Superoxid-Radikal-Freisetzung bei juveniler rheumatoider Arthritis. Klin Wochenschr 60:561–565PubMedCrossRef Rister M, Bauermeister K (1982) Superoxid-Dismutase und Superoxid-Radikal-Freisetzung bei juveniler rheumatoider Arthritis. Klin Wochenschr 60:561–565PubMedCrossRef
33.
go back to reference Ozkan Y, Yardım-Akaydın S, Sepici A et al (2007) Oxidative status in rheumatoid arthritis. Clin Rheumatol 26:64–68PubMedCrossRef Ozkan Y, Yardım-Akaydın S, Sepici A et al (2007) Oxidative status in rheumatoid arthritis. Clin Rheumatol 26:64–68PubMedCrossRef
34.
go back to reference Scudder PR, Al-Timimi D, McMurray W et al (1978) Serum copper and related variables in rheumatoid arthritis. Ann Rheum Dis 37:67–70PubMed Scudder PR, Al-Timimi D, McMurray W et al (1978) Serum copper and related variables in rheumatoid arthritis. Ann Rheum Dis 37:67–70PubMed
35.
go back to reference Rasool M, Varalakshmi P (2007) Protective effect of Withania somnifera root powder in relation to lipid peroxidation, antioxidant status, glycoproteins and bone collagen on adjuvant-induced arthritis in rats. Fundam Clin Pharmacol 21:157–164PubMedCrossRef Rasool M, Varalakshmi P (2007) Protective effect of Withania somnifera root powder in relation to lipid peroxidation, antioxidant status, glycoproteins and bone collagen on adjuvant-induced arthritis in rats. Fundam Clin Pharmacol 21:157–164PubMedCrossRef
36.
go back to reference Braven J, Ansari N, Figgitt DP et al (1989) A comparison of glutathione reductase and glutathione peroxidase activities in patients with rheumatoid arthritis and healthy adults. Br J Rheumatol 8:212–215CrossRef Braven J, Ansari N, Figgitt DP et al (1989) A comparison of glutathione reductase and glutathione peroxidase activities in patients with rheumatoid arthritis and healthy adults. Br J Rheumatol 8:212–215CrossRef
37.
go back to reference Munthe E, Jellum E, Aaseth J et al (1986) Gold salts and selenium in the treatment of rheumatoid arthritis. In: Swaak AJG, Koster JF (eds) Free radicals in arthritis diseases. EURAGE, Rijswijk, The Netherlands, pp 121–128 Munthe E, Jellum E, Aaseth J et al (1986) Gold salts and selenium in the treatment of rheumatoid arthritis. In: Swaak AJG, Koster JF (eds) Free radicals in arthritis diseases. EURAGE, Rijswijk, The Netherlands, pp 121–128
38.
go back to reference Islamov BI, Balabanova RM, Funtikov VA (2002) Effect of bioresonance therapy on antioxidant system in lymphocytes in patients with rheumatoid arthritis. Bull Exp Biol Med 134:248–250PubMedCrossRef Islamov BI, Balabanova RM, Funtikov VA (2002) Effect of bioresonance therapy on antioxidant system in lymphocytes in patients with rheumatoid arthritis. Bull Exp Biol Med 134:248–250PubMedCrossRef
39.
go back to reference Tarp U (1986) Selenium and glutathione peroxidase in rheumatoid arthritis. In: Swaak AJG, Koster JF (eds) Free radicals in arthritis diseases. EURAGE, Rijswijk, The Netherlands, pp 69–73 Tarp U (1986) Selenium and glutathione peroxidase in rheumatoid arthritis. In: Swaak AJG, Koster JF (eds) Free radicals in arthritis diseases. EURAGE, Rijswijk, The Netherlands, pp 69–73
40.
go back to reference Mèzes M, Par A, Bartosceiwiecz G et al (1987) Vitamin E content and lipid peroxidation of blood in some chronic inflammatory diseases. Acta Physiol Hung 69:133–138PubMed Mèzes M, Par A, Bartosceiwiecz G et al (1987) Vitamin E content and lipid peroxidation of blood in some chronic inflammatory diseases. Acta Physiol Hung 69:133–138PubMed
41.
go back to reference Abella A, Clerc D, Chalas J et al (1987) Contration en superoxyde dismutase (cuivre et manganese) catalase et glutathion peroxydase dans les hematies, les plaquettes, et le plasma des sujets atteints de polyarthrite rhumatoide. Ann Biol Clin 45:152–155 Abella A, Clerc D, Chalas J et al (1987) Contration en superoxyde dismutase (cuivre et manganese) catalase et glutathion peroxydase dans les hematies, les plaquettes, et le plasma des sujets atteints de polyarthrite rhumatoide. Ann Biol Clin 45:152–155
42.
go back to reference Vanella A, Scalia R, Terminella C et al (1987) Antioxidant enzymatic systems in erythrocytes from patients with rheumatoid arthritis. Pharmacol Res 15:1181–1188 Vanella A, Scalia R, Terminella C et al (1987) Antioxidant enzymatic systems in erythrocytes from patients with rheumatoid arthritis. Pharmacol Res 15:1181–1188
43.
go back to reference Vijayalakshmi T, Muthulakshmi V, Sachdanandam P (1997) Salubrious effect of Semecarpus anacardium against lipid peroxidative changes in adjuvant arthritis studied in rats. Mol Cell Biochem 175:65–69PubMedCrossRef Vijayalakshmi T, Muthulakshmi V, Sachdanandam P (1997) Salubrious effect of Semecarpus anacardium against lipid peroxidative changes in adjuvant arthritis studied in rats. Mol Cell Biochem 175:65–69PubMedCrossRef
44.
go back to reference Tarp U (1989) Selenium glutathione peroxidase in rheumatoid arthritis. Br J Rheumatol 29:158CrossRef Tarp U (1989) Selenium glutathione peroxidase in rheumatoid arthritis. Br J Rheumatol 29:158CrossRef
45.
go back to reference Cimen MYB, Cimen OB, Kacmaz M et al (2000) Oxidant/antioxidant status of the erythrocytes from patients with rheumatoid arthritis. Clin Rheumatol 19:275–277PubMedCrossRef Cimen MYB, Cimen OB, Kacmaz M et al (2000) Oxidant/antioxidant status of the erythrocytes from patients with rheumatoid arthritis. Clin Rheumatol 19:275–277PubMedCrossRef
46.
go back to reference Ramprasad VR, Shanthi P, Sachdanandam P (2005) Evaluation of antioxidant effect of Semecarpus anacardium Linn.nut extract on the components of immune system in adjuvants arthritis. Vasc Pharmacol 42:179–186CrossRef Ramprasad VR, Shanthi P, Sachdanandam P (2005) Evaluation of antioxidant effect of Semecarpus anacardium Linn.nut extract on the components of immune system in adjuvants arthritis. Vasc Pharmacol 42:179–186CrossRef
47.
go back to reference Kerimova AA, Atalay M, Yusifov EY et al (2000) Antioxidant enzymes; possible mechanism of gold compound treatment in rheumatoid arthritis. Pathophysiology 7:209–213PubMedCrossRef Kerimova AA, Atalay M, Yusifov EY et al (2000) Antioxidant enzymes; possible mechanism of gold compound treatment in rheumatoid arthritis. Pathophysiology 7:209–213PubMedCrossRef
48.
go back to reference Kunau WH, Dommes V, Schulz H (1995) Beta-oxidation of fatty acids in mitochondria, peroxisomes, and bacteria: a century of continued progress. Prog Lipid Res 34:267–342PubMedCrossRef Kunau WH, Dommes V, Schulz H (1995) Beta-oxidation of fatty acids in mitochondria, peroxisomes, and bacteria: a century of continued progress. Prog Lipid Res 34:267–342PubMedCrossRef
49.
go back to reference Benhamou PY, Moriscot C, Richard MJ et al (1998) Adenovirus-mediated catalase gene transcription reduces oxidant stress in human, porcine and rat pancreatic islets. Diabetologia 41:1093–1100PubMedCrossRef Benhamou PY, Moriscot C, Richard MJ et al (1998) Adenovirus-mediated catalase gene transcription reduces oxidant stress in human, porcine and rat pancreatic islets. Diabetologia 41:1093–1100PubMedCrossRef
50.
go back to reference El-Sohemy A, Cornelis MC, Park YW et al (2006) Catalase and PPARc2 genotype and risk of rheumatoid arthritis in Koreans. Rheumatol Int 26:388–392PubMedCrossRef El-Sohemy A, Cornelis MC, Park YW et al (2006) Catalase and PPARc2 genotype and risk of rheumatoid arthritis in Koreans. Rheumatol Int 26:388–392PubMedCrossRef
51.
go back to reference Mulherin D, Fitzgerald O, Bresnihan B (1996) Synovial tissue macrophage populations and articular damage in rheumatoid arthritis. Arthritis Rheum 39:115–124PubMedCrossRef Mulherin D, Fitzgerald O, Bresnihan B (1996) Synovial tissue macrophage populations and articular damage in rheumatoid arthritis. Arthritis Rheum 39:115–124PubMedCrossRef
52.
go back to reference Maurice M, Van der Voort E, Vilet A et al (1997) Chronic oxidative stress in rheumatoid arthritis: implication for T cell function. In: Montaguier L, Oliuier R, Pasquier C (eds) Oxidative stress in cancer, AIDS and neurodegenerative diseases. Marcel Dekker, New York, pp 537–546 Maurice M, Van der Voort E, Vilet A et al (1997) Chronic oxidative stress in rheumatoid arthritis: implication for T cell function. In: Montaguier L, Oliuier R, Pasquier C (eds) Oxidative stress in cancer, AIDS and neurodegenerative diseases. Marcel Dekker, New York, pp 537–546
53.
go back to reference Bazzichi L, Ciompi ML, Betti L et al (2002) Impaired glutathione reductase activity and level of collogenase and elastase in synovial fluid in rheumatoid arthritis. Clin Exp Rheumatol 20:761–766PubMed Bazzichi L, Ciompi ML, Betti L et al (2002) Impaired glutathione reductase activity and level of collogenase and elastase in synovial fluid in rheumatoid arthritis. Clin Exp Rheumatol 20:761–766PubMed
54.
go back to reference Hassan MQ, Hadi RA, Al-Rawi ZS et al (2001) The glutathione defense system in the pathogenesis of rheumatoid arthritis. J Appl Toxicol 21:69–73PubMedCrossRef Hassan MQ, Hadi RA, Al-Rawi ZS et al (2001) The glutathione defense system in the pathogenesis of rheumatoid arthritis. J Appl Toxicol 21:69–73PubMedCrossRef
55.
go back to reference Chow CK, Tappel AL (1972) An enzymatic protective mechanism against lipid peroxidation damage to lung of ozone exposed rats. Lipids 7:518–524PubMedCrossRef Chow CK, Tappel AL (1972) An enzymatic protective mechanism against lipid peroxidation damage to lung of ozone exposed rats. Lipids 7:518–524PubMedCrossRef
56.
go back to reference Herve CA, Wait R, Venables PJ (2003) Glucose-6-phosphate isomerase is not a specific autoantigen in rheumatoid arthritis. Rheumatology 42:986–988PubMedCrossRef Herve CA, Wait R, Venables PJ (2003) Glucose-6-phosphate isomerase is not a specific autoantigen in rheumatoid arthritis. Rheumatology 42:986–988PubMedCrossRef
Metadata
Title
The interrelation of glutathione reductase, catalase, glutathione peroxidase, superoxide dismutase, and glucose-6-phosphate in the pathogenesis of rheumatoid arthritis
Authors
Banu Kalpakcioglu
Kazim Şenel
Publication date
01-02-2008
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 2/2008
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-007-0746-3

Other articles of this Issue 2/2008

Clinical Rheumatology 2/2008 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.